Xvivo Perfusion AB (publ)

Direct answer

Xvivo Perfusion AB (publ) is publicly traded on LSE under the ticker 0RKL.L.

Xvivo Perfusion AB (publ) is a specialized medtech company creating advanced technologies for the preservation and perfusion of organs, tissues, and cells, vital for successful transplantation. Founded in 1998 and headquartered in Gothenburg, Sweden, the company extends its operations across Sweden, the United States, the broader regions of North and South America, Europe, the Middle East, Africa, and the Asia...

Can you invest in Xvivo Perfusion AB (publ)?

Yes. Xvivo Perfusion AB (publ) trades publicly on LSE as 0RKL.L.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Xvivo Perfusion AB (publ)

Detailed equity research is provided by MarketSnap.